Catalysts for $AZN

ASTRAZENECA PLC earnings

AstraZeneca Plc — tozorakimab (Phase II Trial Completion)

AstraZeneca Plc — Calquence (Phase I/II Trial Completion)

AstraZeneca Plc — capivasertib (FDA Advisory Committee Meeting)

AstraZeneca Plc — camizestrant (FDA Advisory Committee Meeting)

ASTRAZENECA PLC earnings

AstraZeneca Plc — durvalumab (Phase III Trial Completion)

WAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM) — FDA approval

BEYFORTUS (NIRSEVIMAB-ALIP) — FDA approval

CALQUENCE (ACALABRUTINIB) — FDA approval

CALQUENCE (ACALABRUTINIB MALEATE) — FDA approval

WAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM) — FDA approval

IMFINZI (DURVALUMAB) — FDA approval

KOSELUGO (SELUMETINIB) — FDA approval

KOSELUGO (SELUMETINIB SULFATE) — FDA approval

TRUQAP (CAPIVASERTIB) — FDA approval

ASTRAZENECA PHARMACEUTICALS recall (Cls II)

BEYFORTUS (NIRSEVIMAB-ALIP) — FDA approval

TEZSPIRE (TEZEPELUMAB-EKKO) — FDA approval

KOSELUGO (SELUMETINIB) — FDA approval

KOSELUGO (SELUMETINIB SULFATE) — FDA approval

WAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM) — FDA approval

IMFINZI (DURVALUMAB) — FDA approval

IMFINZI (DURVALUMAB) — FDA approval

TRUQAP (CAPIVASERTIB) — FDA approval

CALQUENCE (ACALABRUTINIB) — FDA approval

CALQUENCE (ACALABRUTINIB MALEATE) — FDA approval

IMFINZI (DURVALUMAB) — FDA approval

WAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM) — FDA approval

TRUQAP (CAPIVASERTIB) — FDA approval